Search

Disclaimer:

Citron does not guarantee in any way that it is providing all of the information that may be available. We recommend that you do your own due diligence before buying or selling any security. At any times the principals of Citron might hold a position in any of the securities profiled on the site. Citron will not report when a position is initiated or covered. Each investor must make that decision based on his/her judgment of the market.

Andrew Left, Executive Editor

Andrew Left has the longest published and most highly predictive track record of any market commentator or columnist on the specific topic of fraudulent and over-hyped stocks. Mr. Left has been quoted in the Wall Street Journal, Barrons, and Fortune, and he has been interviewed on CNBC. Mr. Left was an invited panelist at Columbia University's China Business Conference 2012, and his research on Longtop Financial is excerpted with permission in a Harvard University Business School case study.

China Biotics (NASDAQ:CHBT)

stock ticker: CHBT

“Where are the stores ?”  Update August 31, 2010…Either the Company does not know how to communicate…or it is a fraud.  You decide.

China Biotics (NASDAQ:CHBT) is out with a response to Citron’s report of yesterday, in which we questioned the accuracy and credibility of the company’s disclosures.  The company is hosting an “Investor Day” in Shanghai “by reservation only”.  Citron suggests that this event is unlikely to produce credible answers needed to tough questions about all the aspects of this company’s disclosures that don’t line up with reality. (more…)

It Doesn’t Take a Microscope to See What’s Wrong with China-Biotics (NASDAQ:CHBT)

stock ticker: CHBT

It Doesn’t Take a Microscope to See What’s Wrong with China-Biotics (NASDAQ:CHBT)
Citron Probes the Obvious:  Where are the Stores?

Amazing how fraud is like water, it just finds the path of least resistance.  When Citron started this column nine years ago this week, the frauds were OTCBB stock promotions run out of boiler rooms.  The progressed to internet campaigns and mailers, and now most recently to the greatest promotion of ‘em all:  CHINA.   In this past weekend’s Barron’s Magazine, Bill Alpert does a fine job in describing the web of fraud that exists in small cap Chinese stocks that were brought to market via reverse merger. (more…)